ArticleSurgery today2026
Early pleurodesis at initial chest tube drainage for malignant pleural effusion: a retrospective single-center study.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMalignant pleural effusion (MPE) impairs the quality of life and it may interrupt systemic cancer therapy. In Japan, indwelling pleural catheters are unavailable, and the optimal timing for pleurodesis remains unclear. We examined whether pleurodesis performed during the initial chest tube drainage for MPE was associated with fewer reinterventions.
methodsWe retrospectively reviewed the patients who underwent initial chest tube drainage for MPE at the Osaka International Cancer Institute (January 2019-June 2025). The re-intervention analysis included patients with a performance status of 0-1 who continued systemic therapy after drainage. Re-intervention within 180 days was compared between the pleurodesis and non-pleurodesis groups. Propensity score matching (1:1) and competing risk analyses (death as a competing event) were performed.
resultsPleurodesis was performed in 159 patients (67%); pleurodesis-related complications occurred in 17.6% of patients, including empyema in two patients (1.3%). Among 117 eligible patients, re-intervention within 180 days occurred in 11/89 (12.4%) and 10/28 (35.7%) patients in the pleurodesis and non-pleurodesis groups, respectively. In the matched cohort (26 per group), pleurodesis was associated with a lower cumulative incidence of re-intervention (Gray's test, p = 0.033) and a lower subdistribution hazard (sHR 0.215, 95% CI 0.0468-0.9887; p = 0.048).
conclusionIn patients with MPE requiring initial chest tube drainage, pleurodesis at the time of drainage may be associated with fewer reinterventions, although residual confounding remains.
Indexed as
Identifiers
42446709What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.